Neuren Pharma jumps on DAYBUE sales win; short sellers' report now history
Dual-listed across the NASDAQ and ASX, Neuren Pharma (ASX:NEU) has jumped +7% down under in the morning Thursday session as...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
AGG | Ann: AGG NTA 07-08-2025 $1.21659 | 08:08 | 0 | 41 | |||
|
|||||||
AGG | Ann: AGG NTA 06-08-2025 $1.21731 | 07/08/25 | 0 | 48 | |||
|
|||||||
AGG | Ann: AGG NTA 05-08-2025 $1.21629 | 06/08/25 | 0 | 66 | |||
|
|||||||
AGG | Ann: AGG Fund Update - 30 June 2025 | 06/08/25 | 0 | 39 | |||
|
|||||||
AGG | Ann: AGG NTA 04-08-2025 $1.21518 | 05/08/25 | 0 | 51 | |||
|
|||||||
AGG | Ann: AGG NTA 01-08-2025 $1.21250 | 04/08/25 | 0 | 57 | |||
|
|||||||
AGG | Ann: AGG NTA 31-07-2025 $1.21108 | 01/08/25 | 0 | 77 | |||
|
|||||||
AGG | Ann: AGG NTA 30-07-2025 $1.21156 | 31/07/25 | 0 | 70 | |||
|
See All Discussions